Percorso:ANSA > Nuova Europa > News > Symbola,Italy's pharma industry 2nd most prominent in Europe

Symbola,Italy's pharma industry 2nd most prominent in Europe

At 32.2 bn, Germany at 32.9. Important self-sufficient system

08 April, 18:51
(ANSA) - UDINE, 08 APR - ROME, APRIL 8 - "We have a leadership role in Europe in pharmaceutical production, with 32.2 billion euros, immediately after Germany with 32.9 bn." That is one of the ten pieces that work in our country, contained in the document 'Italy in 10 selfies. An economy on a human scale to face the future ', a synthesis of the country's strengths created by the Symbola Foundation, along with Unioncamere and Assocamerestero, and presented today at an online conference.

Being ranked 'second' is even more critical if you think of the current situation, facing a health emergency from Covid-19. To win this challenge, we look forward to accelerating the vaccine campaign, and even considering the recent problems in the supply of vaccine doses, we hope for a vaccine production that can meet our needs.

"This is a crucial sector," underlined the president of Symbola, Ermete Realacci. Linking this Italian 'talent' precisely to the "pandemic," he said that "we have seen how important it is for Europe to have a self-sufficient production system in terms of vaccines; among other things, we must also push on with medical treatments as well as vaccines." (ANSA).

© Copyright ANSA - All rights reserved